Genalyte Finds $36M

San Diego-based biotech company Genalyte said this morning that it has raised $36M in a new funding round, for its efforts to develop a microchip-based testing platform. The funding was led by Khosla Ventures and Redmile Group. Genalyte is led by founder and CEO Cary Gunn. The company is initially targeting rheumatology offices with its technology. More information »